Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Goetz

Showing results (241-250 of 397) with videos related to

Pageof 40
Sort By:
Cancer|May 12, 2017
North Central Cancer Treatment Group N0543 (Alliance): A phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinomaRobert R McWilliams, Nathan R Foster, Michelle R Mahoney, et al.
Breast Cancer Research and Treatment|January 11, 2015
A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2Celine M Vachon, Daniel J Schaid, James N Ingle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifenMatthew P Goetz, Vera J Suman, James N Ingle, et al.
NPJ Breast Cancer|April 26, 2024
Impact of dose reductions on adjuvant abemaciclib efficacy for patients with high-risk early breast cancer: analyses from the monarchE studyMatthew P Goetz, Irfan Cicin, Laura Testa, et al.
Neoplasma|January 1, 1981
Clastogenicity and sister chromatid exchange induction by ftorafurM Vrba, R Adámek, M Blasko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imagingRajini Katipamula, Amy C Degnim, Tanya Hoskin, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 28, 2018
ERβ-mediated induction of cystatins results in suppression of TGFβ signaling and inhibition of triple-negative breast cancer metastasisJordan M Reese, Elizabeth S Bruinsma, Adam W Nelson, et al.
Molecular Therapy. Methods & Clinical Development|September 12, 2022
Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an <i>H</i> <i>.</i> <i>pylori</i> immunostimulatory bacterial transgeneKimberly B Viker, Michael B Steele, Ianko D Iankov, et al.
Nature Materials|November 21, 2023
Ultrafast vibrational control of organohalide perovskite optoelectronic devices using vibrationally promoted electronic resonanceNathaniel P Gallop, Dmitry R Maslennikov, Navendu Mondal, et al.
NPJ Breast Cancer|June 19, 2021
Establishment and characterization of immortalized human breast cancer cell lines from breast cancer patient-derived xenografts (PDX)Yongxian Zhuang, Jordan M Grainger, Peter T Vedell, et al.
Pageof 40

Showing results (241-250 of 397) with videos related to

Sort By:
Pageof 40
Cancer|May 12, 2017
North Central Cancer Treatment Group N0543 (Alliance): A phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinomaRobert R McWilliams, Nathan R Foster, Michelle R Mahoney, et al.
Breast Cancer Research and Treatment|January 11, 2015
A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2Celine M Vachon, Daniel J Schaid, James N Ingle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifenMatthew P Goetz, Vera J Suman, James N Ingle, et al.
NPJ Breast Cancer|April 26, 2024
Impact of dose reductions on adjuvant abemaciclib efficacy for patients with high-risk early breast cancer: analyses from the monarchE studyMatthew P Goetz, Irfan Cicin, Laura Testa, et al.
Neoplasma|January 1, 1981
Clastogenicity and sister chromatid exchange induction by ftorafurM Vrba, R Adámek, M Blasko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imagingRajini Katipamula, Amy C Degnim, Tanya Hoskin, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 28, 2018
ERβ-mediated induction of cystatins results in suppression of TGFβ signaling and inhibition of triple-negative breast cancer metastasisJordan M Reese, Elizabeth S Bruinsma, Adam W Nelson, et al.
Molecular Therapy. Methods & Clinical Development|September 12, 2022
Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an <i>H</i> <i>.</i> <i>pylori</i> immunostimulatory bacterial transgeneKimberly B Viker, Michael B Steele, Ianko D Iankov, et al.
Nature Materials|November 21, 2023
Ultrafast vibrational control of organohalide perovskite optoelectronic devices using vibrationally promoted electronic resonanceNathaniel P Gallop, Dmitry R Maslennikov, Navendu Mondal, et al.
NPJ Breast Cancer|June 19, 2021
Establishment and characterization of immortalized human breast cancer cell lines from breast cancer patient-derived xenografts (PDX)Yongxian Zhuang, Jordan M Grainger, Peter T Vedell, et al.
Pageof 40